BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7406380)

  • 1. Hypophosphatemic osteomalacia: association with prostatic carcinoma.
    Lyles KW; Berry WR; Haussler M; Harrelson JM; Drezner MK
    Ann Intern Med; 1980 Aug; 93(2):275-8. PubMed ID: 7406380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
    Drezner MK; Feinglos MN
    J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry.
    Siris ES; Clemens TL; Dempster DW; Shane E; Segre GV; Lindsay R; Bilezikian JP
    Am J Med; 1987 Feb; 82(2):307-12. PubMed ID: 3812526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
    J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-induced vitamin D-resistant hypophosphatemic osteomalacia associated with proximal renal tubular dysfunction and 1,25-dihydroxyvitamin D deficiency.
    Fukumoto Y; Tarui S; Tsukiyama K; Ichihara K; Moriwaki K; Nonaka K; Mizushima T; Kobayashi Y; Dokoh S; Fukunaga M; Morita R
    J Clin Endocrinol Metab; 1979 Dec; 49(6):873-8. PubMed ID: 117020
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
    Miyauchi A; Fukase M; Tsutsumi M; Fujita T
    J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer-induced oncogenic hypophosphatemic osteomalacia.
    Nakahama H; Nakanishi T; Uno H; Takaoka T; Taji N; Uyama O; Kitada O; Sugita M; Miyauchi A; Sugishita T
    Urol Int; 1995; 55(1):38-40. PubMed ID: 7571183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.
    Reid IR; Teitelbaum SL; Dusso A; Whyte MP
    Am J Med; 1987 Aug; 83(2):350-4. PubMed ID: 3303928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dense bone metastases and hypophosphatemic osteomalacia during the course of prostatic cancer (author's transl)].
    Quilichini R; Aubert L; Chauvin M; Chaffanjon P; Eisinger J
    Sem Hop; 1979 Dec 18-25; 55(43-44):2037-9. PubMed ID: 233449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor induced osteomalacia.
    Ioakimidis DE; Dendrinos GK; Frangia KB; Babiolakis DN; Chilas GI; Lyberopoulos KL; Kontomerkos TK
    J Rheumatol; 1994 Jun; 21(6):1162-4. PubMed ID: 7932437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumoral hypophosphoremic osteomalacia].
    Koeger AC; Prier A; Vinceneux P; Camus JP
    Presse Med; 1985 Oct; 14(33):1747-51. PubMed ID: 2933649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
    Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
    Hoshino C; Satoh N; Sugawara S; Kuriyama C; Kikuchi A; Ohta M
    Intern Med; 2008; 47(5):453-7. PubMed ID: 18310982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoparathyroidism: a possible cause of osteomalacia .
    Drezner MK; Neelon FA; Jowsey J; Lebovitz HE
    J Clin Endocrinol Metab; 1977 Jul; 45(1):114-22. PubMed ID: 874058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolism and bone histomorphometry in a patient with antacid-induced osteomalacia.
    Godsall JW; Baron R; Insogna KL
    Am J Med; 1984 Oct; 77(4):747-50. PubMed ID: 6486152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophosphataemic osteomalacia associated with prostatic carcinoma.
    Murphy P; Wright G; Rai GS
    Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1945. PubMed ID: 3924318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.